Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Inhibrx Biosciences (INBX) Other Gross PP&E Adjustments (2023 - 2025)

Inhibrx Biosciences (INBX) has disclosed Other Gross PP&E Adjustments for 3 consecutive years, with $9.3 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 20.17% to $9.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.3 million through Dec 2025, up 20.17% year-over-year, with the annual reading at $9.3 million for FY2025, 20.17% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $9.3 million at Inhibrx Biosciences, up from $8.9 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $13.6 million in Q3 2024, with the low at $7.8 million in Q4 2024.
  • Average Other Gross PP&E Adjustments over 3 years is $10.0 million, with a median of $9.1 million recorded in 2025.
  • Peak annual rise in Other Gross PP&E Adjustments hit 20.17% in 2025, while the deepest fall reached 34.58% in 2025.
  • Over 3 years, Other Gross PP&E Adjustments stood at $10.2 million in 2023, then dropped by 23.63% to $7.8 million in 2024, then increased by 20.17% to $9.3 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $9.3 million, $8.9 million, and $8.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.